Fintel reports that on January 7, 2025, RBC Capital initiated coverage of ICON Public Limited (NasdaqGS:ICLR) with a Outperform recommendation.
Analyst Price Forecast Suggests 33.30% Upside
As of December 23, 2024, the average one-year price target for ICON Public Limited is $287.28/share. The forecasts range from a low of $234.32 to a high of $393.75. The average price target represents an increase of 33.30% from its latest reported closing price of $215.51 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for ICON Public Limited is 9,077MM, an increase of 9.27%. The projected annual non-GAAP EPS is 16.24.
What is the Fund Sentiment?
There are 1,211 funds or institutions reporting positions in ICON Public Limited. This is an decrease of 23 owner(s) or 1.86% in the last quarter. Average portfolio weight of all funds dedicated to ICLR is -1.61%, an increase of 354.43%. Total shares owned by institutions increased in the last three months by 1.54% to 101,323K shares. 
The put/call ratio of ICLR is 2.12, indicating a bearish outlook.
What are Other Shareholders Doing?
Wcm Investment Management holds 6,654K shares representing 8.06% ownership of the company. In its prior filing, the firm reported owning 6,673K shares , representing a decrease of 0.29%. The firm decreased its portfolio allocation in ICLR by 12.83% over the last quarter.
Massachusetts Financial Services holds 4,064K shares representing 4.92% ownership of the company. In its prior filing, the firm reported owning 5,003K shares , representing a decrease of 23.12%. The firm decreased its portfolio allocation in ICLR by 88.83% over the last quarter.
Price T Rowe Associates holds 3,351K shares representing 4.06% ownership of the company. In its prior filing, the firm reported owning 2,619K shares , representing an increase of 21.83%. The firm increased its portfolio allocation in ICLR by 12.81% over the last quarter.
Wellington Management Group Llp holds 3,082K shares representing 3.73% ownership of the company. In its prior filing, the firm reported owning 2,760K shares , representing an increase of 10.46%. The firm decreased its portfolio allocation in ICLR by 85.92% over the last quarter.
Ninety One UK holds 2,696K shares representing 3.27% ownership of the company. In its prior filing, the firm reported owning 2,678K shares , representing an increase of 0.67%. The firm decreased its portfolio allocation in ICLR by 10.81% over the last quarter.
Icon Background Information
(This description is provided by the company.)
ICON plc is a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON employed approximately 15,730 employees in 93 locations in 41 countries as at December 31, 2020.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
